COVID-19 Serology Assays: To test or not to test?

Get in Touch

Our Locations

Patrice Hugo, Ph.D.

COVID-19 Serology Assays: To test or not to test?

Part 1 in this COVID-19 webinar series, presented on June 2, 2020

Overview of the immune response to COVID-19 infection
Diagnostic testing concepts
Serology tests to estimate COVID-19 exposure in the general population
How Serology tests can be the basis of “Certificate of Immunity”
Serology tests and laboratory solutions to support clinical trials

Related Services & Solutions

Related Thought Leaders Insights

Factsheet

Your clinical trial sample tracking solution — enhanced

Subject samples are the lifeblood of your clinical trials. To be successful, you need a unique solution that can track samples through their full lifecycles — across the ecosystem of sites, labs,...

Scientific Poster

Evaluation of Single Cell RNA Sequencing from FFPE Tissue using 10x Genomics Chromium Gene Expression Flex Assay

Single cell RNA sequencing (scRNA-seq) uncovers tissue heterogeneity by providing gene expression measurements in individual cells within a tissue. A current limitation of scRNA-seq is the...

Scientific Poster

Comprehensive Genomic Profiling in FFPE Tissue Sample using TruSight Oncology 500 Assay

Next generation sequencing (NGS)-based comprehensive genomic profiling has emerged as a powerful tool for the large-scale detection of genomic changes. TruSight Oncology 500 (TSO500) Assay employs a...